Esther Ramírez Herráiz (E Ramírez)

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 5

Top Topics

Bipolar Disorder

Prognostic Factors

Rheumatoid Arthritis Patients

Ejection Fraction

Top Venues

Scientific reports

Journal of clinical medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Esteban Daudén, Isabel Belinchón-Romero, Elena González-Colominas, P Coto, Pablo de la Cueva-Dobao, F Gallardo, José Luis Poveda-Andrés, Esther Ramírez Herráiz, Sandra Ros, Ricardo Ruiz Villaverde, Marta Comellas, Luís Lizán
Defining well-being in psoriasis: A Delphi consensus among healthcare professionals and patients. Scientific reports 14 (1) (2024)
Esteban Daudén, Isabel Belinchón-Romero, Elena González-Colominas, P Coto, Pablo de la Cueva-Dobao, F Gallardo, José Luis Poveda-Andrés, Esther Ramírez Herráiz, Sandra Ros, Ricardo Ruiz Villaverde, Marta Comellas, Luís Lizán
Defining well-being in psoriasis: A Delphi consensus among healthcare professionals and patients. Scientific reports 14 (1) (2024)
Alberto Calvo-Garcia, Esther Ramírez Herráiz, Irene María Llorente Cubas, Blanca Varas De Dios, Juana Benedí González, Alberto Morell Baladrón, Rosario García de Vicuña
The Real-World Effectiveness, Persistence, Adherence, and Safety of Janus Kinase Inhibitor Baricitinib in Rheumatoid Arthritis: A Long-Term Study. Journal of clinical medicine 13 (9) (2024)
Esteban Daudén, Isabel Belinchón-Romero, Elena González-Colominas, P Coto, Pablo de la Cueva-Dobao, F Gallardo, José Luis Poveda-Andrés, Esther Ramírez Herráiz, Sandra Ros, Ricardo Ruiz Villaverde, Marta Comellas, Luís Lizán
Defining well-being in psoriasis: A Delphi consensus among healthcare professionals and patients. Scientific reports 14 (1) (2024)
Alberto Calvo-Garcia, Esther Ramírez Herráiz, Irene María Llorente Cubas, Blanca Varas De Dios, Juana Benedí González, Alberto Morell Baladrón, Rosario García de Vicuña
The Real-World Effectiveness, Persistence, Adherence, and Safety of Janus Kinase Inhibitor Baricitinib in Rheumatoid Arthritis: A Long-Term Study. Journal of clinical medicine 13 (9) (2024)